Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06806033 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of March 2, 2026: Clinical trial NCT06806033 is currently recruiting participants. This clinical trial study for diffuse large b-cell lymphoma is actively seeking new participants at 26 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06806033 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06806033 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.